<p>Example of a baseline scenario of our model where vaccination becomes available in season 10, causing a change in the vaccine coverage each season (blue), the seasonal infection incidence (green), the probability that a susceptible individual practices NPIs given that they encounter one or more infectious individuals on a given day (black), and the probability that an infectious individual practices NPIs while ill (red). Confidence intervals represent two standard deviations of outputs for the 100 parameter sets.</p
Simulations from January 1, 2020 until December 31, 2021 performed with the model that has been cali...
BACKGROUND: The way we formulate a mathematical model of an infectious disease to capture symptomati...
<p>Univariate sensitivity analysis for parameters <i>E</i><sub><i>S</i></sub>, <i>E</i><sub><i>H</i>...
<p>(a), (b) Univariate sensitivity analysis for vaccine efficacy, <i>ϵ</i><sub><i>V</i></sub>. Data ...
<p>(a), (b) Univariate sensitivity analysis for NPI efficacy, <i>ϵ</i><sub><i>NPI</i></sub>. Data sh...
<p>Univariate analysis for <i>E</i><sub><i>V</i></sub> and <i>E</i><sub><i>I</i></sub> determining t...
<p>Example time series of vaccination (blue) and incidence (green) over a season. When a vaccine bec...
<p>Univariate sensitivity analysis for <i>E</i><sub><i>V</i></sub> and <i>E</i><sub><i>I</i></sub>. ...
<p>The relative cumulative incidence of severe RVGE after versus before vaccine introduction in indi...
Simulation pairs varied with respect to the proportion of vaccine efficacy due to protection from in...
Vaccine effect, as measured in clinical trials, may not accurately reflect population-level impact. ...
<p>The reduction in the incidence of severe RVGE during a 10-year period beginning 10 years after va...
The way we formulate a mathematical model of an infectious disease to capture symptomatic and asympt...
Simulation pairs varied with respect to the proportion of vaccine efficacy due to protection from in...
grantor: University of TorontoUsing epidemic simulations in randomly mixing and stratifie...
Simulations from January 1, 2020 until December 31, 2021 performed with the model that has been cali...
BACKGROUND: The way we formulate a mathematical model of an infectious disease to capture symptomati...
<p>Univariate sensitivity analysis for parameters <i>E</i><sub><i>S</i></sub>, <i>E</i><sub><i>H</i>...
<p>(a), (b) Univariate sensitivity analysis for vaccine efficacy, <i>ϵ</i><sub><i>V</i></sub>. Data ...
<p>(a), (b) Univariate sensitivity analysis for NPI efficacy, <i>ϵ</i><sub><i>NPI</i></sub>. Data sh...
<p>Univariate analysis for <i>E</i><sub><i>V</i></sub> and <i>E</i><sub><i>I</i></sub> determining t...
<p>Example time series of vaccination (blue) and incidence (green) over a season. When a vaccine bec...
<p>Univariate sensitivity analysis for <i>E</i><sub><i>V</i></sub> and <i>E</i><sub><i>I</i></sub>. ...
<p>The relative cumulative incidence of severe RVGE after versus before vaccine introduction in indi...
Simulation pairs varied with respect to the proportion of vaccine efficacy due to protection from in...
Vaccine effect, as measured in clinical trials, may not accurately reflect population-level impact. ...
<p>The reduction in the incidence of severe RVGE during a 10-year period beginning 10 years after va...
The way we formulate a mathematical model of an infectious disease to capture symptomatic and asympt...
Simulation pairs varied with respect to the proportion of vaccine efficacy due to protection from in...
grantor: University of TorontoUsing epidemic simulations in randomly mixing and stratifie...
Simulations from January 1, 2020 until December 31, 2021 performed with the model that has been cali...
BACKGROUND: The way we formulate a mathematical model of an infectious disease to capture symptomati...
<p>Univariate sensitivity analysis for parameters <i>E</i><sub><i>S</i></sub>, <i>E</i><sub><i>H</i>...